- Home
- OTLK vs MPU Comparison
OTLK vs MPU Comparison
Compare OTLK & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- MPU
- Stock Information
- Founded
- OTLK 2010
- MPU 1989
- Country
- OTLK United States
- MPU Singapore
- Employees
- OTLK N/A
- MPU N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- MPU Transportation Services
- Sector
- OTLK Health Care
- MPU Consumer Discretionary
- Exchange
- OTLK Nasdaq
- MPU Nasdaq
- Market Cap
- OTLK 38.7M
- MPU 43.5M
- IPO Year
- OTLK 2016
- MPU 1998
- Fundamental
- Price
- OTLK $1.20
- MPU $0.70
- Analyst Decision
- OTLK Strong Buy
- MPU
- Analyst Count
- OTLK 5
- MPU 0
- Target Price
- OTLK $10.20
- MPU N/A
- AVG Volume (30 Days)
- OTLK 374.0K
- MPU 116.9K
- Earning Date
- OTLK 05-14-2025
- MPU 05-07-2025
- Dividend Yield
- OTLK N/A
- MPU N/A
- EPS Growth
- OTLK N/A
- MPU N/A
- EPS
- OTLK N/A
- MPU N/A
- Revenue
- OTLK N/A
- MPU $36,184,000.00
- Revenue This Year
- OTLK N/A
- MPU N/A
- Revenue Next Year
- OTLK $288.46
- MPU N/A
- P/E Ratio
- OTLK N/A
- MPU N/A
- Revenue Growth
- OTLK N/A
- MPU N/A
- 52 Week Low
- OTLK $0.87
- MPU $0.49
- 52 Week High
- OTLK $9.98
- MPU $2.99
- Technical
- Relative Strength Index (RSI)
- OTLK 34.06
- MPU 48.77
- Support Level
- OTLK $1.15
- MPU $0.60
- Resistance Level
- OTLK $1.31
- MPU $0.84
- Average True Range (ATR)
- OTLK 0.12
- MPU 0.09
- MACD
- OTLK -0.01
- MPU 0.03
- Stochastic Oscillator
- OTLK 20.45
- MPU 58.88
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.